Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment

BACKGROUND: Liquid biopsy has evolved from being a promising line to becoming a validated approach for biomarker testing. However, its utility for individualization of therapy has been scarcely reported. In this study, we show how monitoring levels of EGFR mutation in plasma can be useful for the in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Provencio, Mariano, Torrente, María, Calvo, Virgina, Gutiérrez, Lourdes, Pérez-Callejo, David, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, Rodriguez-Alfonso, Begoña, Sotelo, Miguel, Cruz-Bermúdez, Juan Luis, Mendez, Miriam, Cruz-Bermúdez, Alberto, Romero, Atocha
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601139/
https://ncbi.nlm.nih.gov/pubmed/28947971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars